We are live on ! Find out more
IHAM

Integral Health Asset Management Portfolio holdings

AUM $2.09B
1-Year Est. Return 112.84%
This Fund
S&P 500
This Quarter Est. Return
+28.42%
1 Year Est. Return
+112.84%
3 Year Est. Return
+485.32%
5 Year Est. Return
+783.01%
10 Year Est. Return
–
AUM
$257M
AUM Growth
–
Cap. Flow
+$237M
Cap. Flow %
92.26%
Top 10 Hldgs %
42.13%
Holding
50
New
50
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
SAGE
Sage Therapeutics
SAGE
+$14.8M
2
A icon
Agilent Technologies
A
+$13.4M
3
MDT icon
Medtronic
MDT
+$11.5M
4
DXCM icon
DexCom
DXCM
+$11.4M
5
BMY icon
Bristol-Myers Squibb
BMY
+$10.9M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 92.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
A icon
1
Agilent Technologies
A
$38.7B
$14.5M 5.65%
+170,000
New +$13.4M
DXCM icon
2
DexCom
DXCM
$31.4B
$13.1M 5.11%
+240,000
New +$11.4M
BMY icon
3
Bristol-Myers Squibb
BMY
$131B
$12.2M 4.75%
+190,000
New +$10.9M
MDT icon
4
Medtronic
MDT
$108B
$11.9M 4.64%
+105,000
New +$11.5M
AMED
5
DELISTED
Amedisys
AMED
$10.8M 4.22%
+65,000
New +$9.67M
SNY icon
6
Sanofi
SNY
$102B
$9.54M 3.71%
+190,000
New +$8.9M
BMRN icon
7
BioMarin Pharmaceuticals
BMRN
$11.5B
$9.3M 3.62%
+110,000
New +$8.31M
AGIO icon
8
Agios Pharmaceuticals
AGIO
$1.92B
$9.07M 3.53%
+190,000
New +$7.18M
BSX icon
9
Boston Scientific
BSX
$66.5B
$9.04M 3.52%
+200,000
New +$8.37M
SAGE
10
DELISTED
Sage Therapeutics
SAGE
$8.66M 3.37%
+120,000
New +$14.8M
DGX icon
11
Quest Diagnostics
DGX
$25.8B
$8.54M 3.33%
+80,000
New +$8.34M
VAR
12
DELISTED
Varian Medical Systems, Inc.
VAR
$8.52M 3.32%
+60,000
New +$7.65M
HUM icon
13
Humana
HUM
$44.1B
$8.43M 3.28%
+23,000
New +$7.29M
ABBV icon
14
AbbVie
ABBV
$446B
$8.41M 3.28%
+95,000
New +$7.89M
TFX icon
15
Teleflex
TFX
$5.79B
$7.91M 3.08%
+21,000
New +$7.23M
CNC icon
16
Centene
CNC
$30.2B
$7.86M 3.06%
+125,000
New +$6.78M
CVS icon
17
CVS Health
CVS
$134B
$7.43M 2.89%
+100,000
New +$7.02M
KPTI icon
18
Karyopharm Therapeutics
KPTI
$54.4M
$6.61M 2.58%
+23,000
New +$4.99M
LLY icon
19
Eli Lilly
LLY
$1.01T
$6.57M 2.56%
+50,000
New +$5.8M
NUVA
20
DELISTED
NuVasive, Inc.
NUVA
$6.19M 2.41%
+80,000
New +$5.65M
GH icon
21
Guardant Health
GH
$21.6B
$5.47M 2.13%
+70,000
New +$5.04M
DRNA
22
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$4.41M 1.72%
+200,000
New +$4.02M
SWAV
23
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
$3.95M 1.54%
+90,000
New +$3.32M
QURE icon
24
uniQure
QURE
$3.09B
$3.94M 1.53%
+55,000
New +$3.02M
AMRN
25
Amarin Corp
AMRN
$292M
$3.75M 1.46%
+8,750
New +$3.32M
1
2

Similar funds

CL
CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return
ACM
Analog Century Management New York $2.09B AUM 186.85% 1-Year Est. Return
NSCM
New South Capital Management Memphis, Tennessee $2.09B AUM 33.67% 1-Year Est. Return
ACG
Aventail Capital Group New York $2.09B AUM 43.81% 1-Year Est. Return
NSUP
NLB Skladi upravljanje premozenja Ljubljana $2.09B AUM
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
ACP
Avantyr Capital Partners New York $2.08B AUM
TA
TruWealth Advisors Metairie, Louisiana $2.08B AUM 21.15% 1-Year Est. Return

Integral Health Asset Management's Q4 2019 Portfolio in Review

Q4 2019 is the first quarter with a 13F filing on record for Integral Health Asset Management, which disclosed 50 positions worth $257M. Its ten largest holdings account for 42% of the portfolio.

Its largest position is Sage Therapeutics: 120,000 shares worth $8.66M.

By sector, the portfolio is most concentrated in Healthcare at 93% of assets.

  • Integral Health Asset Management's largest Q4 2019 buy was Sage Therapeutics: 120,000 shares worth $8.66M.
  • Integral Health Asset Management's ten largest holdings make up 42% of its $257M portfolio in Q4 2019.
  • Integral Health Asset Management disclosed 50 positions in Q4 2019, its first 13F filing on record.

Based on Integral Health Asset Management's 13F filing for Q4 2019, filed 13 Feb 2020.